A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Trial Profile

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs BLI 400 (Primary) ; Lubiprostone
  • Indications Constipation
  • Focus Registrational; Therapeutic Use
  • Sponsors Braintree Laboratories
  • Most Recent Events

    • 25 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 03 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov record.
    • 02 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top